Skip to main content
. 2016 Jul 11;24(9):511–519. doi: 10.1007/s12471-016-0857-z

Table 3.

Pharmacological treatment and intra-aortic balloon pump (IABP)

TTC (%)
n = 95 (SD)
Anterior STEMI (%)
n = 101 (SD)
p
GP IIb/IIIa inhibitors 31,7
– Abciximab 12.9
– Eptifibatide 18.8
Heparin 91.6 98.0 0.0419
– Unfractionated heparin 36.8 57.4 0.0038
– Enoxaparin 52.6 40.6 0.092
– Fondaparinux 2.1 0.0 0.146
Nitroglycerin 14.7 31.7 0.0051
Clopidogrel 82.1 99 <0.0001
Aspirin 97.9 98.0 0.951
Statins 89.5 86.1 0.477
Beta blockers 87.4 89.1 0.705
ACEI/ARB 89.5 82.2 0.144
ACEI 82.1 79.2 0.608
ARB 7.4 3.0 0.163
Calcium blockers 8.4 5.9 0.501
Diuretics 49.5 70.3 0.0029
Proton pump inhibitors 74.7 90.1 0.0045
Pressor amines 13.7 22.0 0.130
Intra-aortic balloon pump 2.11 7.14 0.097

ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, IABP intra-aortic balloon pump